AArkstore enterprise 10th December 2014
Venous Thromboembolism (V TE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Browse Full Report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60322/venous-thromboembolismvte-therapeutics-pipeline-assessment-and-market-forecasts Published: Jan 2012 | No. Of Pages: 75 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
Summary The industry analysis specialist, has released its new report, Venous Thromboembolism (VTE) Therapeutics Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global Venous Thromboembolism Therapeutics market. The report identifies the key trends shaping and driving the global Venous Thromboembolism Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Venous Thromboembolism Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope The report provides information on the key drivers and challenges of the Venous Thromboembolism Therapeutics market. Its scope includesAnnualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Venous Thromboembolism Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
Website : http://www.aarkstore.com/
AArkstore enterprise Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. Analysis of the current and future competition in the seven key countries Venous Thromboembolism Therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Venous Thromboembolism Therapeutics market. Analysis of key recent licensing and partnership agreements in Venous Thromboembolism Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. Develop business strategies by understanding the trends shaping and driving the global Venous Thromboembolism Therapeutics market. Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Venous Thromboembolism Therapeutics market in future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. What’s the next big thing in the global Venous Thromboembolism Therapeutics market landscape? – Identify, understand and capitalize.
Website : http://www.aarkstore.com/
AArkstore enterprise
Special Discount on Global Data Market Research Reports: Click here an avail Discount offer on Global Data market research reports: http://www.aarkstore.com/discount.php Discount Valid till 31st December 2014 For Research Reports Call us on: +91 9987295242 OR Mail us at contact@aarkstore.com
Tables Of Contents 2 Venous Thromboembolism (VTE) Therapeutics - Introduction 7 2.1 Overview 7 2.2 Epidemiology 7 2.3 Etiology 7
Website : http://www.aarkstore.com/
AArkstore enterprise 2.4 Risk Factors 8 2.5 Clinical Presentation / Symptoms 9 2.5.1 Deep Venous Thrombosis (DVT) 9 2.5.2 Pulmonary Embolism (PE) 10 2.6 Diagnosis 10 2.6.1 Deep Venous Thrombosis (DVT) 10 2.6.2 Pulmonary Embolism (PE) 11 2.7 Pathophysiology 11 2.7.1 Deep Venous Thrombosis (DVT) 12 2.7.2 Pulmonary Embolism (PE) 12 2.8 Treatment 12 2.8.1 Deep Venous Thrombosis (DVT) 12 2.8.2 Pulmonary Embolism (PE) 13 2.9 Other Procedures and Devices for VTE 13 2.9.1 Pulmonary Embolectomy 13 2.9.2 Vena Caval Interruption 13 2.9.3 Compression Stockings 13 2.10 GlobalData Pipeline Report Guidance 14 3 VTE Therapeutics - Market Characterization 15 3.1 Overview 15 3.2 VTE Therapeutics Market Size (2005-2010) - Global 16 3.3 VTE Therapeutics Market Forecast (2010-2018) - Global 17 3.4 VTE Therapeutics Market Size (2005-2010) - The US 18
Website : http://www.aarkstore.com/
AArkstore enterprise 3.5 VTE Therapeutics Market Forecast (2010-2018) - The US 19 3.6 VTE Therapeutics Market Size (2005-2010) - France 20 3.7 VTE Therapeutics Market Forecast (2010-2018) - France 21 3.8 VTE Therapeutics Market Size (2005-2010) - Germany 22 3.9 VTE Therapeutics Market Forecast (2010-2018) - Germany 23 3.10 VTE Therapeutics Market Size (2005-2010) - Italy 24 3.11 VTE Therapeutics Market Forecast (2010-2018) - Italy 25 3.12 VTE Therapeutics Market Size (2005-2010) - Spain 26 3.13 VTE Therapeutics Market Forecast (2010-2018) - Spain 27 3.14 VTE Therapeutics Market Size (2005 2010) - The UK 28 3.15 VTE Therapeutics Market Forecast (2010-2018) - The UK 29 3.16 VTE Therapeutics Market Size (2005 2010) - Japan 30 3.17 VTE Therapeutics Market Forecast (2010 2018) - Japan 31 3.18 Drivers and Barriers for the VTE Therapeutics Market 32 3.18.1 Drivers for the VTE Therapeutics Market 32 3.18.2 Barriers for the VTE Therapeutics Market 32 3.19 Opportunity and Unmet Need 33 3.20 Key Takeaway 34 4 VTE Therapeutics Market - Competitive Assessment 35 4.1 Overview 35 4.2 Strategic Competitor Assessment 35 4.3 Product Profiles of the Major Marketed Products in the VTE Therapeutics Market - Heparin Class 36 4.3.1 Enoxaparin 36
Website : http://www.aarkstore.com/
AArkstore enterprise 4.3.2 Dalteparin 37 4.3.3 Warfarin 38 4.3.4 Xarelto 39 4.3.5 Fondaparinux 40 4.3.6 Apixaban (Eliquis) 41 4.4 Key Takeaway 44 5 VTE Therapeutics Market - Pipeline Assessment 45 5.1 Overview 45 5.1.1 VTE Therapeutics - Phase III Clinical Pipeline 45 5.1.2 VTE Therapeutics - Phase II Clinical Pipeline 46 5.1.3 VTE Therapeutics - Phase I Clinical Pipeline 46 5.1.4 VTE Therapeutics - Preclinical and Discovery Clinical Pipeline 46 5.2 VTE Therapeutics Market - Pipeline Assessment by Mechanism of Action 47 5.3 VTE Therapeutics Market - Technology Trends Analytical Framework 48 5.4 VTE Therapeutics Market - Pipeline Assessment by Clinical Phase of Development 50 5.5 VTE Therapeutics - Promising Drugs Under Clinical Development 50 5.6 Molecule Profile for Promising Drugs under Clinical Development 51 5.6.1 Edoxaban (DU-176b) 51 5.7 Key Takeaway 52 6 VTE Therapeutics - Clinical Trials Mapping 53 6.1 Clinical Trials by Region/Country 53 6.2 Clinical Trials by Phase of Clinical Development 54 6.3 Clinical Trials by Trial Status 55
Website : http://www.aarkstore.com/
AArkstore enterprise 6.4 Prominent and Overall Sponsors 56 6.5 Brief Profiles of Top 10 Companies Participating in Clinical Trials 58 7 VTE Therapeutics - Strategic Assessment 59 7.1 Key Events Impacting the Future Market 59 7.2 Future Market Competition Scenario 60 8 VTE Therapeutics - Future Players 61 8.1 Introduction 61 8.2 Company Profiles 62 8.2.1 Boehringer Ingelheim GmbH 62 8.2.2 Bristol-Myers Squibb 63 8.2.3 Daiichi Sankyo 64 8.2.4 Pfizer Inc. 65 8.2.5 Sanofi 66 9 VTE Therapeutics - Acquisition Deals 10 VTE Therapeutics Market - Appendix 10.1 Market Definition 69 10.2 Abbreviations 69 10.3 Methodology 70 10.3.1 Coverage 71 10.3.2 Secondary Research 71 10.3.3 Forecasting 71 10.3.4 Primary Research 74 10.3.5 Expert Panel Validation 74
Website : http://www.aarkstore.com/
AArkstore enterprise 10.4 Contact Us 74 10.5 Disclaimer 74 10.6 Bibliography 75
List Of Tables Table 1: VTE Therapeutics Market, Global, Revenues ($m), 2005 2010 16 Table 2: VTE Therapeutics Market, Global, Market Forecasts ($m), 2010 2018 17 Table 3: VTE Therapeutics Market, The US, Revenue ($m), 2005-2010 18 Table 4: VTE Therapeutics Market, The US, Market Forecasts ($m), 2010-2018 19 Table 5: VTE Therapeutics Market, France, Revenue ($m), 2005-2010 20 Table 6: VTE Therapeutics Market, France, Market Forecast ($m), 2010-2018 21 Table 7: VTE Therapeutics Market, Germany, Revenue ($m), 2005-2010 22 Table 8: VTE Therapeutics Market, Germany, Market Forecast ($m), 2010-2018 23 Table 9: VTE Therapeutics Market, Italy, Revenue ($m), 2005-2010 24 Table 10: VTE Therapeutics Market, Italy, Market Forecast ($m), 2010-2018 25 Table 11: VTE Therapeutics Market, Spain, Revenue ($m), 2005-2010 26 Table 12: VTE Therapeutics Market, Spain, Market Forecast ($m), 2010-2018 27 Table 13: VTE Therapeutics Market, The UK, Revenue ($m), 2005-2010 28 Table 14: VTE Therapeutics Market, The UK, Market Forecast ($m), 2010-2018 29 Table 15: VTE Market, Japan, Revenue ($m), 2005-2010 30 Table 16: VTE Therapeutics Market, Japan, Market Forecast ($m), 2010-2018 31 Table 17: Major Marketed Products Comparison in the VTE Therapeutics Market, 2010 43 Table 18: VTE Therapeutics Market - Phase III Clinical Pipeline, 2010 45
Website : http://www.aarkstore.com/
AArkstore enterprise Table 19: VTE Therapeutics Market - Phase II Clinical Pipeline, 2010 46 Table 20: VTE Therapeutics Market - Phase I Clinical Pipeline, 2010 46 Table 21: VTE Therapeutics Market - Preclinical Pipeline, 2010 46 Table 22: VTE Therapeutics - Most Promising Drugs Under Clinical Development, 2010 50 Table 23: VTE Market, Global, Clinical Trials by Country, 2010 53 Table 24: VTE Market, Global, Clinical Trials by Phase, 2010 54 Table 25: VTE Market, Global, Clinical Trials by Status of Development, 2010 55 Table 26: VTE Market, Global, Sponsors, 2010 57 Table 27: VTE Market, Global, Companies by Phase, 2010 58 Table 28: VTE Therapeutics, Global, Deals, 2011 68
List Of Figures Figure 1: DVT: Risk Factors 8 Figure 2: DVT: Clinical Presentation 9 Figure 3: PE: Clinical Presentation 10 Figure 4: VTE Therapeutics Market, Global, Revenues ($m), 2005 2010 16 Figure 5: VTE Therapeutics Market, Global, Market Forecast ($m), 2010 2018 17 Figure 6: VTE Therapeutics Market, The US, Revenue ($m), 2005-2010 18 Figure 7: VTE Therapeutics Market, The US, Market Forecasts ($m), 2010-2018 19 Figure 8: VTE Therapeutics Market, France, Revenue ($m), 2005-2010 20 Figure 9: VTE Therapeutics Market, France, Market Forecast ($m), 2010-2018 21 Figure 10: VTE Therapeutics Market, Germany, Revenue ($m), 2005-2010 22 Figure 11: VTE Therapeutics Market, Germany, Market Forecast ($m), 2010-2018 23
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 12: VTE Therapeutics Market, Italy, Revenue ($m), 2005-2010 24 Figure 13: VTE Therapeutics Market, Italy, Market Forecast ($m), 2010-2018 25 Figure 14: VTE Therapeutics Market, Spain, Revenue ($m), 2005-2010 26 Figure 15: VTE Therapeutics Market, Spain, Market Forecast ($m), 2010-2018 27 Figure 16: VTE Therapeutics Market, The UK, Revenue ($m), 2005-2010 28 Figure 17: VTE Therapeutics Market, The UK, Market Forecast ($m), 2010-2018 29 Figure 18: VTE Therapeutics Market, Japan, Revenue ($m), 2005-2010 30 Figure 19: VTE Therapeutics Market, Japan, Market Forecast ($m), 2010-2018 31 Figure 20: Opportunity and Unmet Need in the VTE Therapeutics Market 33 Figure 21: Strategic Competitor Assessment of the Marketed Products for VTE, 2010 36 Figure 22: VTE Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2010 47 Figure 23: Technology Trends Analytic Framework of the VTE Pipeline, 2010 48 Figure 24: Technology Trends Analytic Framework of the VTE Pipeline - Description, 2010 49 Figure 25: VTE Pipeline by Phase of Clinical Development, 2010 50 Figure 26: VTE Market, Global, Clinical Trials by Country, 2010 53 Figure 27: VTE Market, Global, Clinical Trials by Phase, 2010 54 Figure 28: VTE Market, Global, Clinical Trials by Stage of Development, 2010 55 Figure 29: VTE Market, Global, Prominent Sponsors, 2010 56 Figure 30: VTE Market, Global, Overall Sponsors, 2010 57 Figure 31: VTE, Market, Global, Companies by Phase, 2010 58 Figure 32: VTE Market, Drivers and Barriers, 2010 59 Figure 33: Implications for Future Market Competition in the VTE Therapeutics Market, 2010 60 Figure 34: VTE Therapeutics Market - Clinical Pipeline by Company, 2010 61
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 35: GlobalData Market Forecasting Model 73
Discount Reports: Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019 Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018 Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018
About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60322/venousthromboembolism-vte-therapeutics-pipeline-assessment-and-market-forecasts
Website : http://www.aarkstore.com/
AArkstore enterprise
Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com Facebook: https://www.facebook.com/aarkstoredotcom Linkedin: http://www.linkedin.com/company/aarkstore-enterprise
Website : http://www.aarkstore.com/